Stimcell Energetics Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Stimcell Energetics Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | May 31, 2024 | $0 | Aug 29, 2024 |
| FY2024 | May 31, 2023 | $2.8K | Aug 29, 2024 |
| FY2020 | May 31, 2020 | $95.8K | Sep 15, 2020 |
| FY2020 | May 31, 2019 | $0 | Sep 15, 2020 |
| FY2012 | May 31, 2012 | $0 | Oct 11, 2012 |
| FY2012 | May 31, 2011 | $0 | Oct 11, 2012 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | May 31, 2017 | $6.2K | Sep 13, 2018 |
| FY2017 | May 31, 2016 | $36.6K | Aug 29, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | May 31, 2024 | $0 | Aug 29, 2024 |
| FY2024 | May 31, 2023 | $483 | Aug 29, 2024 |
| FY2023 | May 31, 2022 | $4.0K | Sep 1, 2023 |
| FY2022 | May 31, 2021 | $3.5K | Apr 7, 2023 |
| FY2020 | May 31, 2020 | $85.6K | Sep 15, 2020 |
| FY2020 | May 31, 2019 | $0 | Sep 15, 2020 |
| FY2018 | May 31, 2017 | $2.2K | Sep 13, 2018 |
| FY2017 | May 31, 2016 | $8.1K | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $16.1K | Sep 13, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | May 31, 2022 | ($697.4K) | Apr 7, 2023 |
| FY2022 | May 31, 2021 | ($910.8K) | Apr 7, 2023 |
| FY2021 | May 31, 2020 | ($1.09M) | Aug 30, 2021 |
| FY2020 | May 31, 2019 | ($906.0K) | Sep 15, 2020 |
| FY2019 | May 31, 2018 | ($1.55M) | Sep 6, 2019 |
| FY2018 | May 31, 2017 | ($1.25M) | Sep 13, 2018 |
| FY2017 | May 31, 2016 | ($2.14M) | Aug 29, 2017 |
| FY2016 | May 31, 2015 | ($1.03M) | Sep 13, 2016 |
| FY2015 | May 31, 2014 | ($18.5K) | Sep 3, 2015 |
| FY2014 | May 31, 2013 | ($12.6K) | Aug 26, 2014 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | May 31, 2023 | $89.2K | Sep 1, 2023 |
| FY2023 | May 31, 2022 | $150.7K | Sep 1, 2023 |
| FY2022 | May 31, 2021 | $229.6K | Apr 7, 2023 |
| FY2021 | May 31, 2020 | $393.2K | Aug 30, 2021 |
| FY2020 | May 31, 2019 | $261.9K | Sep 15, 2020 |
| FY2019 | May 31, 2018 | $418.3K | Sep 6, 2019 |
| FY2018 | May 31, 2017 | $297.0K | Sep 13, 2018 |
| FY2017 | May 31, 2016 | $650.4K | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $177.9K | Sep 13, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($141.6K) | Sep 2, 2025 |
| FY2025 | May 31, 2024 | ($145.9K) | Sep 2, 2025 |
| FY2024 | May 31, 2023 | ($272.2K) | Aug 29, 2024 |
| FY2023 | May 31, 2022 | ($450.6K) | Sep 1, 2023 |
| FY2022 | May 31, 2021 | ($560.4K) | Apr 7, 2023 |
| FY2018 | May 31, 2018 | ($449.4K) | Sep 13, 2018 |
| FY2018 | May 31, 2017 | ($754.1K) | Sep 13, 2018 |
| FY2017 | May 31, 2016 | ($421.6K) | Aug 29, 2017 |
| FY2016 | May 31, 2015 | ($316.8K) | Sep 13, 2016 |
| FY2015 | May 31, 2014 | ($9.8K) | Sep 3, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | May 31, 2022 | $0 | Apr 7, 2023 |
| FY2022 | May 31, 2021 | $1.6K | Apr 7, 2023 |
| FY2021 | May 31, 2020 | $2.5K | Aug 30, 2021 |
| FY2020 | May 31, 2019 | $1.9K | Sep 15, 2020 |
| FY2019 | May 31, 2018 | $0 | Sep 6, 2019 |
| FY2018 | May 31, 2017 | $110.2K | Sep 13, 2018 |
| FY2017 | May 31, 2016 | $218.8K | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $27.8K | Sep 13, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $21.2K | Sep 2, 2025 |
| FY2025 | May 31, 2024 | $46.1K | Sep 2, 2025 |
| FY2024 | May 31, 2023 | $103.3K | Aug 29, 2024 |
| FY2023 | May 31, 2022 | $41.3K | Sep 1, 2023 |
| FY2022 | May 31, 2021 | $52.2K | Apr 7, 2023 |
| FY2021 | May 31, 2020 | $159.2K | Aug 30, 2021 |
| FY2020 | May 31, 2019 | $190.5K | Sep 15, 2020 |
| FY2019 | May 31, 2018 | $45.3K | Sep 6, 2019 |
| FY2018 | May 31, 2017 | $293.7K | Sep 13, 2018 |
| FY2017 | May 31, 2016 | $268.9K | Aug 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $1.27M | Sep 2, 2025 |
| FY2025 | May 31, 2024 | $872.6K | Sep 2, 2025 |
| FY2024 | May 31, 2023 | $2.49M | Aug 29, 2024 |
| FY2023 | May 31, 2022 | $2.05M | Sep 1, 2023 |
| FY2022 | May 31, 2021 | $1.63M | Apr 7, 2023 |
| FY2021 | May 31, 2020 | $1.68M | Aug 30, 2021 |
| FY2020 | May 31, 2019 | $1.96M | Sep 15, 2020 |
| FY2019 | May 31, 2018 | $1.12M | Sep 6, 2019 |
| FY2018 | May 31, 2017 | $1.46M | Sep 13, 2018 |
| FY2017 | May 31, 2016 | $1.68M | Aug 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | May 31, 2018 | ($1.07M) | Sep 13, 2018 |
| FY2018 | May 31, 2017 | ($1.17M) | Sep 13, 2018 |
| FY2018 | May 31, 2016 | ($1.41M) | Sep 13, 2018 |
| FY2017 | May 31, 2015 | ($684.1K) | Aug 29, 2017 |
| FY2015 | May 31, 2014 | ($20.4K) | Sep 3, 2015 |
| FY2015 | May 31, 2013 | ($1.9K) | Sep 3, 2015 |
| FY2014 | May 31, 2012 | $10.8K | Aug 26, 2014 |
| FY2013 | May 31, 2011 | ($3.4K) | Jul 17, 2014 |
| FY2013 | May 31, 2010 | $10.2K | Jul 17, 2014 |
| FY2013 | Mar 18, 2010 | $0 | Jul 17, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($10.86M) | Sep 2, 2025 |
| FY2025 | May 31, 2024 | ($10.30M) | Sep 2, 2025 |
| FY2024 | May 31, 2023 | ($10.15M) | Aug 29, 2024 |
| FY2023 | May 31, 2022 | ($9.66M) | Sep 1, 2023 |
| FY2022 | May 31, 2021 | ($8.96M) | Apr 7, 2023 |
| FY2021 | May 31, 2020 | ($8.05M) | Aug 30, 2021 |
| FY2020 | May 31, 2019 | ($6.96M) | Sep 15, 2020 |
| FY2019 | May 31, 2018 | ($6.05M) | Sep 6, 2019 |
| FY2018 | May 31, 2017 | ($4.50M) | Sep 13, 2018 |
| FY2017 | May 31, 2016 | ($3.25M) | Aug 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | May 31, 2021 | $20.8K | Aug 30, 2021 |
| FY2021 | May 31, 2020 | $45.1K | Aug 30, 2021 |
| FY2021 | May 31, 2019 | $57.2K | Aug 30, 2021 |
| FY2020 | May 31, 2018 | $8.2K | Sep 15, 2020 |
| FY2019 | May 31, 2017 | $67.5K | Sep 6, 2019 |
| FY2018 | May 31, 2016 | $27.6K | Sep 13, 2018 |
| FY2017 | May 31, 2015 | $1.3K | Aug 29, 2017 |
| FY2015 | May 31, 2014 | $1.2K | Sep 3, 2015 |
| FY2014 | May 31, 2013 | $11.0K | Aug 26, 2014 |
| FY2013 | May 31, 2012 | $23.6K | Jul 17, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 0 | Sep 2, 2025 |
| FY2025 | May 31, 2024 | 0 | Sep 2, 2025 |
| FY2024 | May 31, 2023 | 0 | Aug 29, 2024 |
| FY2023 | May 31, 2022 | 0 | Sep 1, 2023 |
| FY2022 | May 31, 2021 | 0 | Apr 7, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | May 31, 2018 | 44.28M | Sep 13, 2018 |
| FY2018 | May 31, 2017 | 40.24M | Sep 13, 2018 |
| FY2017 | May 31, 2016 | 31.00M | Aug 29, 2017 |